| Heading: |
Dementia: Medical Treatments |
| Question ID: |
1791534 |
| UIN: |
43455 |
| House: |
Commons |
| Date tabled: |
2025-04-02 |
| Asking Member ID: |
4131 |
| Asking Member display name: |
Jim Shannon
|
| Asking Member handle: |
jimshannonmp
|
| Asking Member Twitter reference: |
@jimshannonmp
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure that new treatments for (a) Alzheimer’s disease and (b) other dementias are made available to people in the UK. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-04-10 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4359 |
| Answering Member display name: |
Stephen Kinnock
|
| Answering Member handle: |
skinnock
|
| Answering Member Twitter reference: |
@skinnock
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service in England on whether new medicines should be routinely funded, based on an assessment of their costs and benefits. The NICE evaluates all n... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |